Katalog Plus
Bibliothek der Frankfurt UAS
Bald neuer Katalog: sichern Sie sich schon vorab Ihre persönlichen Merklisten im Nutzerkonto: Anleitung.
Dieses Ergebnis aus Supplemental Index kann Gästen nicht angezeigt werden.  Login für vollen Zugriff.

BO-112 Plus Pembrolizumab for Patients With Anti–PD-1–Resistant Advanced Melanoma: Phase II Clinical Trial SPOTLIGHT-203.

Title: BO-112 Plus Pembrolizumab for Patients With Anti–PD-1–Resistant Advanced Melanoma: Phase II Clinical Trial SPOTLIGHT-203.
Authors: Márquez-Rodas, Iván1 (AUTHOR) ivanpantic@hotmail.com; Dutriaux, Caroline2 (AUTHOR); Saiag, Philippe3 (AUTHOR); de la Cruz Merino, Luis4 (AUTHOR); Castañón Álvarez, Eduardo5 (AUTHOR); Robert, Caroline6 (AUTHOR); Rodríguez-Moreno, Juan F.7 (AUTHOR); Arance, Ana8 (AUTHOR); Cerezuela-Fuentes, Pablo9 (AUTHOR); Montaudié, Henri10 (AUTHOR); Sanmamed, Miguel F.11 (AUTHOR); González-Cao, María12 (AUTHOR); Charles, Julie13 (AUTHOR); López Criado, María Pilar14 (AUTHOR); Berrocal, Alfonso15 (AUTHOR); de Miguel, Enrique1 (AUTHOR); Funck-Brentano, Elisa3 (AUTHOR); Prey, Sorilla2 (AUTHOR); Álamo de la Gala, Mᵃ Carmen16 (AUTHOR); Melero, Ignacio11 (AUTHOR)
Source: Journal of Clinical Oncology. 9/1/2025, Vol. 43 Issue 25, p2806-2815. 12p.
Database: Supplemental Index